Let the money flow like the Mississippi River
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Green green green brother
Time to move on up to the moon brother
Hang in there brothers got some green$$$$$$
Run forest run in the sea of red$$$$$$
Hold my hand and push while we pray
The time has come to shock the world breakthrough
Let’s break through brothers breakthrough up ahead
Let’s see forest green today $$$$$$$
This type of high tech breakthrough could rattle the international scientific community
Rnaz is going to shine in the sea of red brothers rna powerhouse breakthrough
Time to shine in the sea of red brothers. This high tech pharma about to get serious
Unleash the beast of Epigenetics
The tides have turned brothers my eyes watching now
Foxo Keys to AI platforms brothers
World is about to find out what epigenetics Ai is all about… fasten your seat belts brothers it’s going to get loud in here
Foxo Technologies is a shining star on the world stage
https://cltalent.net/
The epigenetics sectors boom Item 1.01 Entry into a Material Definitive Agreement.
Corporate Development Advisory Agreement
On July 25, 2024, the board of directors of FOXO Technologies Inc., a Delaware corporation (the “Company”), approved the Company entering into the Corporate Development Advisory Agreement (the “Advisory Agreement”) with C L Talent Inc. (the “Consultant”). Pursuant to the Advisory Agreement, commencing July 17, 2024, the Consultant will reasonably be available during regular business hours to advise, counsel and inform designated officers and employees of the Company about the health, wellness and social media businesses in which the Company is engaged, competitors, business opportunities, talent engagement and other aspects of or concerning the Company’s business about which the Consultant has knowledge or expertise. In addition, the Consultant will assist the Company with targeting key talent with whom the Company has an existing relationship to further enhance market reach. The term of the Advisory Agreement is 12 months
https://cltalent.net/about/
FOXO Technologies Formalizes License Agreement with KR8.ai to Power New Epigenetic Wellness Solutions
Reports planned commercial launch of VITHAR™ AI Health Coach Proceeding Ahead of Schedule
January 22, 2024 08:30 AM Eastern Standard Time
MINNEAPOLIS--(BUSINESS WIRE)--FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”), a leader in the field of commercializing epigenetic biomarker technology, today announced it has formalized its collaboration with KR8.ai Inc. (“KR8”) and secured the exclusive license to KR8’s AI-based software to support the development and commercial launch of its new health and wellness offering - the VITHAR™ AI Health Coach. As previously announced, the Company is in the process of launching its new subscription-based, direct-to-consumer product offering that is designed to provide personalized health and wellness recommendations, by combining: (i) FOXO’s machine learning models to analyze epigenetic biomarkers; (ii) the Company’s expertise and algorithms correlating epigenetic analysis with health outcomes; and (iii) published, peer-reviewed, clinical data and other verified, third-party health resources.
Mark White, Interim CEO of FOXO Technologies, stated, “Formalization of this agreement is an important milestone as we advance our new direct-to-consumer offering. By leveraging our epigenetic data, genetic insight and growing patent estate, with KR8’s AI-driven analytic software and proprietary algorithms, we aim to provide the most robust direct-to-consumer health and wellness app in the industry. We believe this offering will provide consumers with unparalleled insight, including a comprehensive risk analysis and actionable health insights to understand their biological age, as well as optimize and better manage their health. Our goal is to quickly and cost-effectively capture a meaningful share of the Health and Fitness App Market size, which was valued at $8.2 billion in 2022 and is projected to reach $35.7 billion by 2030 (Verified Market Research) through an offering that goes way beyond traditional health apps, coupled with a cost-effective go-to-market strategy. The new app will simply require users to send a saliva or blood sample, and the technology will then combine this information with user health stats, as well as peer-reviewed clinical studies and other verified health resources to provide customized AI-driven health recommendations. Since initially announcing the collaboration, we have made tremendous progress and are well ahead of schedule with our planned commercial launch. We could not be more excited about the outlook for VITHAR™ and look forward to providing further updates.”
About KR8.ai
KR8.ai harnesses the power of AI-driven analytics to optimize social media accounts’ current performance against their full potential. Their premier mobile application, aptly named 'the KR8 Coach', provides a comprehensive evaluation of an account’s current performance against their full potential. Based on this analysis, it then offers intelligent, AI-derived suggestions to amplify the reach and effectiveness of their posts. Beyond this, KR8 AI's innovative solutions are adaptable and can seamlessly be integrated into third-party, direct-to-consumer applications. This adaptability not only streamlines processes but also results in more economically efficient technology implementations.
About FOXO Technologies Inc. (“FOXO”)
FOXO, a technology platform company, is a leader in epigenetic biomarker discovery and commercialization focused on commercializing longevity science through products and services that serve multiple industries. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. For more information about FOXO, visit www.foxotechnologies.com. For investor information and updates, visit https://foxotechnologies.com/investors/.
Bring it home to the mountain top
https://foxotechnologies.com/home/
Is IBM, Microsoft on Nvidia in full scale production
Green friday close on the double… will stand out of all sea of red
Only a matter of time…Pharma stocks do well in this type of economy that we just entered this morning, takes a few days for the masses to figure this out
AI pharma healthcare stocks going to do well in this type of economy that we just entered this morning, takes a few days for the masses to figure this out
The shorts on their last straw
Dump this shit and move along To the Otc expert market
can’t wait for the big volume dump
50 cents singing with the fat lady brother she can scream alleluia
Did you dump your shares?? Or are you buying?? Make up your mind, no volume are you shaking to load the cheap shares
Their can’t be a levee with no water, dump your shit and move along to the daycare so you can play with kids, leave this to the big boys
Hold my hand brother, we shall pray all day for a healthcare revolution of the 21sr century
Let’s all hold hands and pray for a health care revolution
RNAZ On the world stage
https://informaconnect.com/rna-leaders-usa/
RNAZ On top of the world brothers and sisters
https://informaconnect.com/rna-leaders-usa/speakers/
Live the dream transcode therapeutics
Show the world what you got RNAZ
I had a dream RNaz the next nvidia in medicine Ai
Let’s all holds hands and pray for a breakout today
Lots of developments coming our way
Bingo brother,